Fierce Pharma

FEBRUARY 8, 2024

This week on “The Top Line,” we explore the most anticipated drug launches of 2024. This week on “The Top Line,” we explore the most anticipated drug launches of 2024.

Sales 184

Sales Pharma Marketing 184

Fierce Pharma

SEPTEMBER 20, 2024

Fierce Pharma Asia—Merck's collabs with Daiichi, Eisai deliver readouts; Granules hit with FDA manufacturing observations aliu Fri, 09/20/2024 - 09:21

Manufacturing 183

Manufacturing Pharma FDA 183

PharmExec

NOVEMBER 5, 2024

At the Financial Times’ Global Pharma and Biotech Summit 2024, Christophe Weber, president and CEO, Takeda, discusses how trust and collaboration between the biopharma industry and stakeholders can be implemented to support successful healthcare transformation.

Pharma 52

Pharma Biopharma Healthcare Healthcare 52

Fierce Pharma

OCTOBER 22, 2024

With multiple high-profile production pacts already in the books for 2024, CDMO Samsung Biologics has hooked another big one. Following a string of high-profile deals, Samsung Biologics has locked down a $1.2 billion contract with an unnamed Asia-based pharmaceutical company that’s expected to run through December 2037.

Pharmaceutical 268

Pharmaceutical 268

Fierce Pharma

DECEMBER 21, 2023

Big Pharma companies have often talked about the major opportunities that await in China. | Big Pharma companies have often talked about the major opportunities that await in China. But as price cuts play out and internal priorities shift, multinational companies are reworking their business models in the country.

Pharma 276

Pharma 276

Fierce Pharma

MAY 2, 2024

WuXi Biologics has withdrawn from the 2024 BIO International Convention as the U.S. . | Japan's Ono will buy kinase inhibitor expert Deciphera for $2.4 Novartis invests further in radiopharmaceuticals with two deals. grows hostile against certain Chinese biotech companies. And more.

Pharma 211

Pharma Pharmaceutical 211

PM360

NOVEMBER 2, 2023

Don’t miss your chance to vote for the winners of the 2024 Pharma Choice Awards. Voting will remain open until Dec.

Pharma 98

Pharma 98

Fierce Pharma

OCTOBER 1, 2024

As the landscape of healthcare advertising evolves, how can brands effectively reach their audiences while ensuring da | Fierce Pharma’s Michelle Benz sought to find the answer to this pressing question, sitting down with Mallory Wils, EVP of Sales for healthcare data science advertising specialist BranchLab, during Digital Pharma East 2024.

Pharma 130

Pharma Marketing Healthcare Healthcare 130

Fierce Pharma

JULY 30, 2024

For the first time since its sales peaked during the pandemic, Pfizer registered year-over-year revenue growth during the second quarter of 2024. For more than a year after Pfizer’s COVID product sales peaked at the end of 2022, the company’s quarterly revenues showed year-over-year declines. |

Sales 284

Sales 284

PharmaTech

SEPTEMBER 10, 2024

The 2024 CPHI Pharma Awards comprise finalists spanning 14 categories and includes awards for future leaders, women of the year, and an “at the heart of pharma” category.

Pharma 52

Pharma 52

Fierce Pharma

AUGUST 30, 2024

ESC 2024: UK's George Medicines posts positive results for triple-combo blood pressure drug on heels of FDA submission fkansteiner Fri, 08/30/2024 - 15:54

Medicine 236

Medicine FDA 236

European Pharmaceutical Review

JULY 5, 2024

Following the Labour Party’s win yesterday in the UK 2024 General Election, industry representatives have voiced their opinions on what this could mean for the future of the pharmaceutical industry under the new government. EU pharmacovigilance is stronger with the UK, and UK research is stronger with the EU.”

Pharma 98

Pharma Government Safety Pharmaceutical manufacturing 98

European Pharmaceutical Review

JANUARY 2, 2024

According to results from a survey by GlobalData, the top challenges for the pharmaceutical industry in 2024 will be inflation, geopolitical conflict and drug pricing pressures. Data outcomes revealed that most respondents from Pharma considered that drug pricing and reimbursement constraints will have a negative impact in 2024.

Pharma 102

Pharma Medicine Marketing Government 102

Fierce Pharma

APRIL 1, 2024

The two most influential proxy advisory firms are rallying investors to vote against the 2024 pay proposal for Soriot at the company’s annual general meeting this month. Like clockwork, AstraZeneca CEO Pascal Soriot’s pay is under fire again. Like clockwork, AstraZeneca CEO Pascal Soriot’s pay is under fire again.

294

294

PM360

FEBRUARY 23, 2024

We are proud to present your 15th Annual Pharma Choice Award winners. The greatest healthcare and life sciences creatives of 2023, chosen by the people who know this industry best, are unveiled in this issue. The PharmaChoice awards are quite unlike any other awards in our industry or at PM360 because the winners are picked by the people.

Pharma 52

Pharma Media Sales Healthcare 52

European Pharmaceutical Review

MARCH 1, 2024

Although pharma companies are working steadily to leverage the power of data and become more agile and resilient, there is still room for improvement. The post 2024 Pharmaceutical industry trends – discover the latest pharma quality and manufacturing trends appeared first on European Pharmaceutical Review.

Manufacturing 98

Manufacturing Pharmaceutical Pharma 98

Pharma Marketing Network

DECEMBER 6, 2023

Reuters Events: Pharma USA 2024 is where senior pharma executives from Commercial, Marketing, Medical Affairs, RWE, Market Access, Patient Engagement, as well as key stakeholders, will come together to map out how they can deliver value to overcome the challenges that are hindering scientific innovation. 

Pharma 52

Pharma Networking Marketing Medicine 52

Fierce Pharma

MARCH 27, 2024

WuXi Biologics stays the course with positive 2024 outlook as national security crackdown threatens business in US fkansteiner Wed, 03/27/2024 - 13:12

264

264

Fierce Pharma

JANUARY 23, 2024

Ahead of key Stelara patent cliff, J&J's pharma business churns out growth fkansteiner Tue, 01/23/2024 - 11:32

Pharma 206

Pharma 206

Pharmaceutical Commerce

SEPTEMBER 3, 2024

In an interview with Pharma Commerce Editor Nicholas Saraceno, Ilisa B.G. Bernstein, President of Bernstein Rx Solutions, LLC, highlights the hard-hitting points that she anticipated will be covered during her session at the 2024 HDA Traceability Seminar.

Pharma 105

Pharma 105

Fierce Pharma

DECEMBER 22, 2023

And it is with cautious optimism that industry watchers see the trend continuing in 2024. . | Even with the Federal Trade Commission keeping a watchful eye on the biopharma industry and the economic landscape giving some players pause, mergers and acquisitions are back on the rise.

Biopharma 343

Biopharma 343

MedCity News

OCTOBER 16, 2024

HLTH 2024, scheduled for October 20-23 at the Venetian Expo Center in Las Vegas, will highlight the shifting landscape of healthcare innovation in many different settings. The post 12 Compelling Sessions to Check Out at HLTH 2024 appeared first on MedCity News. Register today!

Healthcare 111

Healthcare Healthcare Pharma 111

MedCity News

FEBRUARY 14, 2024

2024 presents an exciting yet challenging landscape for global pharma marketers.

Marketing 97

Marketing Pharma Pharmaceutical Patients 97

Fierce Pharma

JANUARY 5, 2024

The last few days of 2023 and the beginning of 2024 featured a flurry of dealmaking by the likes of AstraZeneca, Johnson & Johnson, Roche and Boehringer Ingelheim with Asian companies | A flurry of deals were inked by the likes of AstraZeneca, Johnson & Johnson, Roche and Boehringer Ingelheim with Asian companies.

Pharma 190

Pharma 190

Pharma Marketing Network

JUNE 18, 2024

Show that pharma is driven by more than profit – to build a world that empowers all patients and leaves no one in the dark. Welcome to Pharma & Patient USA, the co-created event for patient champions in pharma, who won’t sit back. THIS is the real value of your work. Are you ready to be the new beacon of trust?

Pharma 52

Pharma Patients Networking Healthcare 52

Fierce Pharma

APRIL 4, 2024

Fierce Pharma Asia—Eisai's subQ Leqembi delay; Legend and J&J's supply deal with Novartis; China's Ozempic biosimilar aliu Thu, 04/04/2024 - 16:14

Pharma 130

Pharma 130

Fierce Pharma

OCTOBER 1, 2024

Join us for an exciting interview straight from Digital Pharma East 2024! Join us for an exciting interview straight from Digital Pharma East 2024!

Healthcare 130

Healthcare Healthcare Marketing Pharma 130

Fierce Pharma

FEBRUARY 1, 2024

On both fronts, Sanofi expects to see dividends in 2024. . | As Sanofi strives to become a global immunology leader, it's also busy making the most of a crucial respiratory launch with partner AstraZeneca.

261

261

Fierce Pharma

OCTOBER 1, 2024

When it comes to pharma marketing in 2024, there is perhaps no bigger discussion than privacy. When it comes to pharma marketing in 2024, there is perhaps no bigger discussion than privacy.

Media 130

Media Pharma Marketing 130

Fierce Pharma

JANUARY 4, 2024

In 2024, CDMOs can advance their priorities on three fronts, a group of experts said during a recent Evaluate webinar on the state of the industry. Even after the heady highs of the COVID-19 era, the contract development and manufacturing organization (CDMO) realm remains one of biopharma's buzziest fields.

Biopharma 275

Biopharma Manufacturing 275

Tribeca Knowledge

DECEMBER 12, 2023

In our pharma trends for 2024, we look at some critical market access challenges in key territories for industry, and how companies can best prepare for them over the coming year.

Marketing 52

Marketing Pharma Pharmaceutical 52

PharmExec

NOVEMBER 7, 2024

At the Financial Times’ Global Pharma and Biotech Summit 2024, a panel discussed ways to prepare for the high number of incoming patent expiries and how to protect key drugs.

Pharma 52

Pharma 52

Fierce Pharma

JANUARY 3, 2024

Expect more of the same in 2024, according to a report from Evaluate, which places Novo and Lilly in the top two spots for global new sales.

Sales 284

Sales Biopharma Leads Marketing 284

Fierce Pharma

JULY 1, 2024

Welcome to Fierce Pharma's regulatory tracker for the second half of 2024. | In this tracker, Fierce Pharma is recording the regulatory progress of in-market products, including expansions into key geographies and new indications.

Pharma 227

Pharma FDA Marketing 227

Fierce Pharma

APRIL 11, 2024

As lawmakers, biopharma companies and others try to stabilize vulnerable pharma supply chains, drug shortages have become about as bad as they’ve ever been in the U.S. | as of 2024’s first quarter—the highest number recorded since ASHP began tracking shortage data back in 2001.

Biopharma 317

Biopharma Pharma 317

Pharmaceutical Commerce

MAY 9, 2024

In an interview with Pharma Commerce Editor Nicholas Saraceno, Cathy O'Brien, VP of Sales, UPS Healthcare discusses her masterclass on delivering agility in supply chains by building a multimodal cold chain network while also reducing risks at LogiPharma Europe 2024.

Networking 105

Networking Sales Pharma Healthcare 105

Fierce Pharma

SEPTEMBER 7, 2023

Analysts anticipate that the trend will continue in 2023 and into 2024 as companies attempt to beef up their portfolios. Biopharma M&A is on an uptick compared to the post-pandemic doldrums of the last two years. Biopharma M&A is on an uptick compared to the post-pandemic doldrums of the last two years.

Biopharma 327

Biopharma Pharma 327